|
1
|
Klein OR, Buddenbaum J, Tucker N, Chen AR,
Gamper CJ, Loeb D, Zambidis E, Llosa NJ, Huo JS, Robey N, et al:
Nonmyeloablative haploidentical bone marrow transplantation with
post-transplantation cyclophosphamide for pediatric and young adult
patients with high-risk hematologic malignancies. Biol Blood Marrow
Transplant. 23:325–332. 2017. View Article : Google Scholar
|
|
2
|
Sengsayadeth S, Savani BN, Blaise D and
Mohty M: Haploidentical transplantation: Selecting optimal
conditioning regimen and stem cell source. Semin Hematol.
53:111–114. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Storek J, Geddes M, Khan F, Huard B, Helg
C, Chalandon Y, Passweg J, Roosnek E, et al: Reconstitution of the
immune system after hematopoietic stem cell transplantation in
humans. Semin Immunopathol. 30:425–437. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Krenger W, Blazar BR and Hollander GA:
Thymic T-cell development in allogeneic stem cell transplantation.
Blood. 117:6768–6776. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Simons L, Cavazzana M and Andre I: Concise
Review: Boosting T-cell reconstitution following allogeneic
transplantation-current concepts and future perspectives. Stem
Cells Transl Med. 8:650–657. 2019.PubMed/NCBI
|
|
6
|
Chaudhry MS, Velardi E, Malard F and van
den Brink MR: Immune reconstitution after allogeneic hematopoietic
stem cell transplantation: Time to T up the thymus. J Immunol.
198:40–46. 2017. View Article : Google Scholar
|
|
7
|
Rossi SW, Jeker LT, Ueno T, Kuse S, Keller
MP, Zuklys S, Gudkov AV, Takahama Y, Krenger W, Blazar BR and
Holländer GA: Keratinocyte growth factor (KGF) enhances postnatal
T-cell development via enhancements in proliferation and function
of thymic epithelial cells. Blood. 109:3803–3811. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alpdogan O, Hubbard VM, Smith OM, Patel N,
Lu S, Goldberg GL, Gray DH, Feinman J, Kochman AA, Eng JM, et al:
Keratinocyte growth factor (KGF) is required for postnatal thymic
regeneration. Blood. 107:2453–2460. 2006. View Article : Google Scholar
|
|
9
|
Sun L, Li H, Luo H and Zhao Y: Thymic
epithelial cell development and its dysfunction in human diseases.
Biomed Res Int. 2014:2069292014.PubMed/NCBI
|
|
10
|
Jenkinson WE, Jenkinson EJ and Anderson G:
Differential requirement for mesenchyme in the proliferation and
maturation of thymic epithelial progenitors. J Exp Med.
198:325–332. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wertheimer T, Velardi E, Tsai J, Cooper K,
Xiao S, Kloss CC, Ottmüller KJ, Mokhtari Z, Brede C, deRoos P, et
al: Production of BMP4 by endothelial cells is crucial for
endogenous thymic regeneration. Sci Immunol. 3:eaal27362018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Perry JSA, Russler-Germain EV, Zhou YW,
Purtha W, Cooper ML, Choi J, Schroeder MA, Salazar V, Egawa T, Lee
BC, et al: Transfer of cell-surface antigens by scavenger receptor
CD36 promotes thymic regulatory T cell receptor repertoire
development and allotolerance. Immunity. 48:12712018. View Article : Google Scholar
|
|
13
|
Rasko JE, Metcalf D, Rossner MT, Begley CG
and Nicola NA: The flt3/flk-2 ligand: Receptor distribution and
action on murine haemopoietic cell survival and proliferation.
Leukemia. 9:2058–2066. 1995.PubMed/NCBI
|
|
14
|
Sitnicka E, Buza-Vidas N, Ahlenius H,
Cilio CM, Gekas C, Nygren JM, Månsson R, Cheng M, Jensen CT,
Svensson M, et al: Critical role of FLT3 ligand in IL-7 receptor
independent T lymphopoiesis and regulation of lymphoid-primed
multipotent progenitors. Blood. 110:2955–2964. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Williams KM, Moore AR, Lucas PJ, Wang J,
Bare CV and Gress RE: FLT3 ligand regulates thymic precursor cells
and hematopoietic stem cells through interactions with CXCR4 and
the marrow niche. Exp Hematol. 52:40–49. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tan JT, Dudl E, LeRoy E, Murray R, Sprent
J, Weinberg KI and Surh CD: IL-7 is critical for homeostatic
proliferation and survival of naive T cells. Proc Natl Acad Sci
USA. 98:8732–8737. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kondrack RM, Harbertson J, Tan JT, McBreen
ME, Surh CD and Bradley LM: Interleukin 7 regulates the survival
and generation of memory CD4 cells. J Exp Med. 198:1797–1806. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Murali-Krishna K, Lau LL, Sambhara S,
Lemonnier F, Altman J and Ahmed R: Persistence of memory CD8 T
cells in MHC class I-deficient mice. Science. 286:1377–1381. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cho KA, Kim YH, Park M, Kim HJ, Woo SY,
Park JW and Ryu KH: Conditioned medium from human palatine tonsil
mesenchymal stem cells attenuates acute graft-vs.-host disease in
mice. Mol Med Rep. 19:609–616. 2019.
|
|
20
|
Kim JY, Park M, Kim YH, Ryu KH, Lee KH,
Cho KA and Woo SY: Tonsil-derived mesenchymal stem cells (T-MSCs)
prevent Th17-mediated autoimmune response via regulation of the
programmed death-1/programmed death ligand-1 (PD-1/PD-L1) pathway.
J Tissue Eng Regen Med. 12:e1022–e1033. 2018. View Article : Google Scholar
|
|
21
|
Cho KA, Park M, Kim YH, Ryu KH and Woo SY:
Poly I:C primes the suppressive function of human palatine
tonsil-derived MSCs against Th17 differentiation by increasing
PD-L1 expression. Immunobiology. 222:394–398. 2017. View Article : Google Scholar
|
|
22
|
Park M, Kim YH, Ryu JH, Woo SY and Ryu KH:
Immune suppressive effects of tonsil-derived mesenchymal stem cells
on mouse bone-marrow-derived dendritic cells. Stem Cells Int.
2015:1065402015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim YH, Cho KA, Lee HJ, Park M, Shin SJ,
Park JW, Woo SY and Ryu KH: Conditioned medium from human
tonsil-derived mesenchymal stem cells enhances bone marrow
engraftment via endothelial cell restoration by pleiotrophin.
Cells. 9:2212020. View Article : Google Scholar :
|
|
24
|
Gyurkocza B and Sandmaier BM: Conditioning
regimens for hematopoietic cell transplantation: One size does not
fit all. Blood. 124:344–353. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Soares MV, Azevedo RI, Ferreira IA, Bucar
S, Ribeiro AC, Vieira A, Pereira PNG, Ribeiro RM, Ligeiro D, Alho
AC, et al: Naive and stem cell memory T cell subset recovery
reveals opposing reconstitution patterns in CD4 and CD8 T cells in
chronic graft vs. host disease Front Immunol. 10:3342019.
View Article : Google Scholar
|
|
26
|
Alachkar H and Nakamura Y: Deep-sequencing
of the T-cell receptor repertoire in patients with haplo-cord and
matched-donor transplants. Chimerism. 6:47–49. 2015. View Article : Google Scholar
|
|
27
|
Krenger W, Rossi S and Hollander GA:
Apoptosis of thymocytes during acute graft-versus-host disease is
independent of gluco-corticoids. Transplantation. 69:2190–2193.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ashwell JD, Lu FW and Vacchio MS:
Glucocorticoids in T cell development and function. Annu Rev
Immunol. 18:309–345. 2000. View Article : Google Scholar
|
|
29
|
Douek DC, Vescio RA, Betts MR, Brenchley
JM, Hill BJ, Zhang L, Berenson JR, Collins RH and Koup RA:
Assessment of thymic output in adults after haematopoietic
stem-cell transplantation and prediction of T-cell reconstitution.
Lancet. 355:1875–1881. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Seo YD, Jiang X, Sullivan KM, Jalikis FG,
Smythe KS, Abbasi A, Vignali M, Park JO, Daniel SK, Pollack SM, et
al: Mobilization of CD8+ T Cells via CXCR4 blockade
facilitates PD-1 checkpoint therapy in human pancreatic cancer.
Clin Cancer Res. 25:3934–3945. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Toivonen R, Arstila TP and Hanninen A:
Islet-associated T-cell receptor-β CDR sequence repertoire in
prediabetic NOD mice reveals antigen-driven T-cell expansion and
shared usage of VβJβ TCR chains. Mol Immunol. 64:127–135. 2015.
View Article : Google Scholar
|
|
32
|
Perko R, Kang G, Sunkara A, Leung W,
Thomas PG and Dallas MH: Gamma delta T cell reconstitution is
associated with fewer infections and improved event-free survival
after hema-topoietic stem cell transplantation for pediatric
leukemia. Biol Blood Marrow Transplant. 21:130–136. 2015.
View Article : Google Scholar
|
|
33
|
Handgretinger R and Schilbach K: The
potential role of gammadelta T cells after allogeneic HCT for
leukemia. Blood. 131:1063–1072. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Minculescu L, Marquart HV, Ryder LP,
Andersen NS, Schjoedt I, Friis LS, Kornblit BT, Petersen SL,
Haastrup E, Fischer-Nielsen A, et al: Improved overall survival,
relapse-free-survival, and less Graft-vs.-host-disease in patients
with high immune reconstitution of TCR gamma delta cells 2 months
after allogeneic stem Cell Transplantation. Front Immunol.
10:19972019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Barreto R, Waning DL, Gao H, Liu Y,
Zimmers TA and Bonetto A: Chemotherapy-related cachexia is
associated with mitochondrial depletion and the activation of
ERK1/2 and p38 MAPKs. Oncotarget. 7:43442–43460. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gu W, Song L, Li XM, Wang D, Guo XJ and Xu
WG: Mesenchymal stem cells alleviate airway inflammation and
emphysema in COPD through down-regulation of cyclooxygenase-2 via
p38 and ERK MAPK pathways. Sci Rep. 5:87332015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang QQ, Jing XM, Bi YZ, Cao XF, Wang YZ,
Li YX, Qiao BJ, Chen Y, Hao YL and Hu J: Human Umbilical Cord
Wharton's Jelly Derived mesenchymal stromal cells may attenuate
sarco-penia in aged mice induced by hindlimb suspension. Med Sci
Monit. 24:9272–9281. 2018. View Article : Google Scholar : PubMed/NCBI
|
